Literature DB >> 23911596

Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.

Jing-Huei Lai1, Hsun-Jin Jan, Li-Wen Liu, Chin-Cheng Lee, Shyang-Guang Wang, Dueng-Yuan Hueng, Yung-Yen Cheng, Horng-Mo Lee, Hsin-I Ma.   

Abstract

BACKGROUND: A shift in glucose metabolism from oxidative phosphorylation to anaerobic glycolysis is the biochemical hallmark of malignant cancer cells.
METHODS: In the present study, we demonstrated that Nodal stimulated the expression of glycolytic enzymes and decreased reliance on mitochondrial oxidative phosphorylation in human glioma cancer cells. The shift in glucose metabolism was mediated by induction of the hypoxia-inducible factor (HIF).
RESULTS: Nodal protein expression was shown to be correlated with expression levels of glucose transporter (Glut)-1, hexokinase (HK)-II, pyruvate dehydrogenase kinase (PDK)-1, the phosphorylation level of pyruvate dehydrogenase (PDH), glucose uptake, and lactate accumulation in human glioma cells. These effects were inversely correlated with mitochondrial oxygen consumption and ATP production. Knockdown of Nodal expression with specific small hairpin RNA reduced Glut-1, HK-II, and PDK-1 expressions and PDH phosphorylation. Nodal knockdown also reduced glucose uptake and lactate generation, which in turn increased mitochondrial membrane potential (Ψ), O2 utilization, and ATP synthesis. The ectopic expression of Nodal in low-expressing Nodal glioma cells resulted in the opposite results compared with those of Nodal knockdown glioma cells. Treatment of cells with recombinant Nodal increased HIF-1 expression, and this effect was regulated at the transcriptional level. Blockage of the Nodal receptor by a pharmacological inhibitor or Nodal knockdown in U87MG cells decreased HIF-1α expression. Furthermore, HIF-1α knockdown in U87MG cells decreased Glut-1, HK-II, and PDK-1 expressions and PDH phosphorylation, which were similar to results in Nodal knockdown cells.
CONCLUSION: Taken together, these results suggest that Nodal affects energy metabolism through HIF-1α.

Entities:  

Keywords:  Glut-1; HIF-1; Nodal; energy metabolism; gliomas

Mesh:

Substances:

Year:  2013        PMID: 23911596      PMCID: PMC3779039          DOI: 10.1093/neuonc/not086

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  23 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria.

Authors:  S P Mathupala; Y H Ko; P L Pedersen
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

3.  Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors.

Authors:  M Muzi; S D Freeman; R C Burrows; R W Wiseman; J M Link; K A Krohn; M M Graham; A M Spence
Journal:  Nucl Med Biol       Date:  2001-02       Impact factor: 2.408

4.  Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes.

Authors:  B Altenberg; K O Greulich
Journal:  Genomics       Date:  2004-12       Impact factor: 5.736

Review 5.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.

Authors:  Maria L Macheda; Suzanne Rogers; James D Best
Journal:  J Cell Physiol       Date:  2005-03       Impact factor: 6.384

6.  Osteopontin regulates human glioma cell invasiveness and tumor growth in mice.

Authors:  Hsun-Jin Jan; Chin-Cheng Lee; Yung-Luen Shih; Dueng-Yuan Hueng; Hsin-I Ma; Jing-Huei Lai; Hen-Wei Wei; Horng-Mo Lee
Journal:  Neuro Oncol       Date:  2009-12-23       Impact factor: 12.300

Review 7.  Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.

Authors:  James Brugarolas; William G Kaelin
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

8.  Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells.

Authors:  Denis Mottet; Valéry Dumont; Yann Deccache; Catherine Demazy; Noelle Ninane; Martine Raes; Carine Michiels
Journal:  J Biol Chem       Date:  2003-05-22       Impact factor: 5.157

9.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.

Authors:  Ioanna Papandreou; Rob A Cairns; Lucrezia Fontana; Ai Lin Lim; Nicholas C Denko
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

10.  SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.

Authors:  Mark D Hjelmeland; Anita B Hjelmeland; Sith Sathornsumetee; Elizabeth D Reese; Michael H Herbstreith; Nicholas J Laping; Henry S Friedman; Darell D Bigner; Xiao-Fan Wang; Jeremy N Rich
Journal:  Mol Cancer Ther       Date:  2004-06       Impact factor: 6.261

View more
  9 in total

1.  XBP1 silencing decreases glioma cell viability and glycolysis possibly by inhibiting HK2 expression.

Authors:  Yaohua Liu; Xu Hou; Min Liu; Zhuowen Yang; Yunke Bi; Huichao Zou; Jianing Wu; Hui Che; Chenguang Li; Xiaoxiong Wang; Kaikai Wang; Chen Zhong; Jiakang Zhang; Tao Yu; Qilong Bian; Shuang Chai; Huailei Liu; Jing Ai; Shiguang Zhao
Journal:  J Neurooncol       Date:  2015-12-17       Impact factor: 4.130

2.  Plasticity underlies tumor progression: role of Nodal signaling.

Authors:  Thomas M Bodenstine; Grace S Chandler; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Cancer Metastasis Rev       Date:  2016-03       Impact factor: 9.264

Review 3.  The Warburg effect: 80 years on.

Authors:  Michelle Potter; Emma Newport; Karl J Morten
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

4.  SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis.

Authors:  Lei Xu; Yang Li; Lixing Zhou; Robert Gregory Dorfman; Li Liu; Rui Cai; Chenfei Jiang; Dehua Tang; Yuming Wang; Xiaoping Zou; Lei Wang; Mingming Zhang
Journal:  Cancer Med       Date:  2019-04-16       Impact factor: 4.452

5.  The Interaction Between Nodal, Hypoxia-Inducible Factor 1 Alpha, and Thrombospondin 1 Promotes Luteolysis in Equine Corpus Luteum.

Authors:  Edyta Walewska; Karolina Wołodko; Dariusz Skarzynski; Graça Ferreira-Dias; António Galvão
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-01       Impact factor: 5.555

6.  Dihuang-Yinzi Alleviates Cognition Deficits via Targeting Energy-Related Metabolism in an Alzheimer Mouse Model as Demonstrated by Integration of Metabolomics and Network Pharmacology.

Authors:  Guanghui Han; Weizhe Zhen; Yuan Dai; Hongni Yu; Dongyue Li; Tao Ma
Journal:  Front Aging Neurosci       Date:  2022-04-01       Impact factor: 5.702

Review 7.  Connexins and Glucose Metabolism in Cancer.

Authors:  Jennifer C Jones; Thomas M Bodenstine
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

8.  Mutant TP53 driving the Warburg Effect in Mantle Cell lymphoma.

Authors:  Johannes Kliebhan; Andrej Besse; Kerstin Kampa-Schittenhelm; Marcus Schittenhelm; Christoph Driessen
Journal:  Clin Case Rep       Date:  2022-10-03

9.  PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2's mitochondria translocation.

Authors:  Xu Hou; Yaohua Liu; Huailei Liu; Xin Chen; Min Liu; Hui Che; Fei Guo; Chunlei Wang; Daming Zhang; Jianing Wu; Xiaofeng Chen; Chen Shen; Chenguang Li; Fei Peng; Yunke Bi; Zhuowen Yang; Guang Yang; Jing Ai; Xin Gao; Shiguang Zhao
Journal:  Sci Rep       Date:  2015-03-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.